Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi®
CORAL GABLES, Fla., March 11, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX),…
Bring Your Toughest AM Quality Problem To Formnext: Amsight Challenges Manufacturers To Rethink Production Quality
Mentionkit Publishes SourcetoMCP Case Study on Social Listening for B2B SaaS